| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/23/2006 | EP1051405B1 Novel dihydroxyhexanoic acid derivatives |
| 08/23/2006 | EP0998916B1 Medicinal compositions for application to mucosa |
| 08/23/2006 | EP0822831B2 Vaccines containing a saponin and a sterol |
| 08/23/2006 | EP0800514B1 Substituted imides as tnf inhibitors |
| 08/23/2006 | CN1823160A Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical proparations |
| 08/23/2006 | CN1823039A Cyclic aminophenyl sulfamate derivative |
| 08/23/2006 | CN1822847A Plant worms mycelium extracat fraction and composition for oral intake |
| 08/23/2006 | CN1821275A Ginseng extracting method for separating ginseng polyose and extract and use of ginseng polyose |
| 08/23/2006 | CN1820759A Tacrolimus solid dispersion and its preparing method |
| 08/23/2006 | CN1820618A Health preserving liver protection tea and its preparing method |
| 08/23/2006 | CN1270757C Chinese traditional medicine for treating purpuric disease and method for making the same |
| 08/23/2006 | CN1270714C Microemulsion preconcentrates containing piperidine substance P antagonist |
| 08/22/2006 | US7094946 Animal model for allergic disorders |
| 08/22/2006 | US7094916 vitamin D3 derivative as anti-cancer agent, for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion, for immune disorders, metabolic bone diseases and also used as antiinflammatory agent |
| 08/22/2006 | US7094899 Vitreous form of known bradykinin antagonist |
| 08/22/2006 | US7094895 Inotropic agents such as (S)-N-tert-butyloxycarbonyl-N-methyl-tyrosyl)-4-(4-nitrophenyl)-piperazine, used for preventing and/or prophylaxis of diseases associated with adenosine 5'-triphosphate |
| 08/22/2006 | US7094802 PKB-3564 substance with neovascularization inhibitory activity |
| 08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
| 08/22/2006 | US7094784 High affinity ligands for nociceptin receptor ORL-1 |
| 08/22/2006 | US7094779 2-(3-indolylmethyl)-1-benzoyl-4-oxime-piperazine derivatives, e.g., 1-{(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(1H-indol-3-ylmethyl)-piperazin-4-yl}-2-propanone O-[2-(dimethylamino)-ethyl]oxime, used for treatment of CNS disorders. |
| 08/22/2006 | US7094776 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease including senile, postmenopausal, and steroid-induced osteoporosis, osteomalacia, renal osteodystrophy and rickets |
| 08/22/2006 | US7094552 Diagnostic test kits |
| 08/22/2006 | US7094419 from an implantable immunomodulation device having an impermeable, yet porous, biocompatible outer shell and an inner lumen of a fibrous scaffolding having an antigen or chemotatic agent sufficient to provoke an immune response |
| 08/22/2006 | US7094411 Avirulent, immunogenic flavivirus chimeras |
| 08/22/2006 | US7094409 Antigen arrays for treatment of allergic eosinophilic diseases |
| 08/22/2006 | US7094405 Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response and T helper cell response in a broad range of MHC type recipients |
| 08/22/2006 | US7094392 Heating antihistamine drug vaporize; cooling to form a condensation aerosol; kit for dispensing thin coating |
| 08/22/2006 | CA2368138C Mechanically stable pharmaceutical presentation form containing liquid or semisolid surface-active substances |
| 08/22/2006 | CA2240927C Process for production of piperidine derivatives |
| 08/17/2006 | WO2006086500A2 Compositions and methods for treating vascular, autoimmune and inflammatory diseases |
| 08/17/2006 | WO2006086498A2 Treatment of vascular, autoimmune and inflammatory diseases using low dosages of impdh inhibitors |
| 08/17/2006 | WO2006086361A2 ANTILYMPHOCYTE ANTIBODY INDUCTION BY COMBINATION OF AN SlP RECEPTOR AGONIST/MODULATOR AND OF IMMUNOSUPPRESSIVE DRUGS |
| 08/17/2006 | WO2006085687A1 Composition containing dihomo-ϝ-linolenic acid (dgla) as the active ingredient |
| 08/17/2006 | WO2006085655A1 Ointment |
| 08/17/2006 | WO2006085553A1 Anti-tlr6 antibody and utilization of the same |
| 08/17/2006 | WO2006085516A1 Support for protein transfer, protein transfer agent using the support, protein transfer method, cell having protein transferred thereinto and method of producing the same |
| 08/17/2006 | WO2006085497A1 Tablet disintegrating in the oral cavity |
| 08/17/2006 | WO2006085096A1 Ligands for g-protein coupled receptors |
| 08/17/2006 | WO2006084975A1 Derivatives of n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, thiourea and urea) as cannabinoid cb1 receptor antagonists |
| 08/17/2006 | WO2006084782A1 Use of iron(iii) complex compounds |
| 08/17/2006 | WO2006084337A1 A molecule and chimeric molecules thereof |
| 08/17/2006 | WO2006084327A1 A molecule and chimeric molecules thereof |
| 08/17/2006 | WO2006067311A3 Cdc25 phosphatase inhibitors |
| 08/17/2006 | WO2006029182A3 Use of mdl-100,907 for treatment of allergic and eosinophil mediated diseases |
| 08/17/2006 | WO2003053346A3 Systems and methods for treating patients with processed lipoaspirate cells |
| 08/17/2006 | US20060183797 Fatty alcohols and fatty acid esters useful for treatment of inflammation |
| 08/17/2006 | US20060183770 Sulfonamide derivative having isoxazole ring |
| 08/17/2006 | US20060183757 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 08/17/2006 | US20060183737 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists |
| 08/17/2006 | US20060183674 Compositions and methods for treating diabetes |
| 08/17/2006 | US20060183664 Pharmaceutical composition for delayed hypersensitivity |
| 08/17/2006 | US20060183199 polynucleotide encoding peptide domain of CD40 ligand lacking a matrix metalloproteinase cleavage sites, used as immunology modulators, vaccines and treatments of human diseases, including malignancies and autoimmune diseases |
| 08/17/2006 | US20060183114 Novel Eosinophil Cationic Proteins used in the Treatement of Asthematic and Allergic Disorders |
| 08/17/2006 | US20060183105 Human brain-derived tissue-specific potassium channel |
| 08/17/2006 | US20060182793 Cpg-packaged liposomes |
| 08/17/2006 | US20060182760 Method for protecting living body from external factor and composition therefor |
| 08/17/2006 | US20060182753 Vaccines |
| 08/17/2006 | US20060182740 Buffered formulations for concentrating antibodies and methods of use thereof |
| 08/17/2006 | CA2599112A1 Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient |
| 08/17/2006 | CA2597583A1 Support for protein transfer, protein transfer agent using the support, protein transfer method, cell having protein transferred thereinto and method of producing the same |
| 08/17/2006 | CA2597537A1 Ointment |
| 08/17/2006 | CA2597481A1 Ligands for g-protein coupled receptors |
| 08/17/2006 | CA2597346A1 A molecule and chimeric molecules thereof |
| 08/17/2006 | CA2596613A1 Derivatives of n-[(4,5-diphenyl-3-alkyl-2-thienyl) methyl] amine (amide, thiourea and urea) as cannabinoid cb1 receptor antagonists |
| 08/17/2006 | CA2595960A1 Antilymphocyte antibody induction by combination of an s1p receptor agonist/modulator and of immunosuppressive drugs |
| 08/16/2006 | EP1690864A2 Tricyclic purine compounds and their analogs as inhibitors of cytokine signalling |
| 08/16/2006 | EP1690549A1 Immunotherapic agent which is used for the combined treatment of tuberculosis together with other pharmaceuticals |
| 08/16/2006 | EP1690545A2 A combination therapy for HIV infections |
| 08/16/2006 | EP1690539A2 Salts of tiotropium for treating inflammatory disorders |
| 08/16/2006 | EP1690538A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor |
| 08/16/2006 | EP1689771A1 Biologically active peptides comprising isoleucyl-valyl-threonyl-asparaginyl-threonyl-threonine (ivtntt) |
| 08/16/2006 | EP1689754A1 42-o-alkoxyalkyl rapamycin derivatives and compositions comprising same |
| 08/16/2006 | EP1689739A1 Azole-based kinase inhibitors |
| 08/16/2006 | EP1689726A1 5-(benz- (z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents |
| 08/16/2006 | EP1689715A1 Tubulin inhibitors |
| 08/16/2006 | EP1689714A2 Therapeutic use of pyridinium compounds to modulate naadp activity |
| 08/16/2006 | EP1689435A1 Anti-thymocyte antiserum and use thereof to trigger b cell apoptosis |
| 08/16/2006 | EP1689434A1 The use of anti biotics as vaccine adjuvants |
| 08/16/2006 | EP1689433A1 Compositions and methods for activating innate and allergic immunity |
| 08/16/2006 | EP1689413A2 Glycerophospholipids containing omega-3 and omega-6 fatty acids |
| 08/16/2006 | EP1513835B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/16/2006 | EP1509241B1 Novel uses of cephaibols |
| 08/16/2006 | EP1377282B1 Aryl-n-cyanoguanidines and methods related thereto |
| 08/16/2006 | EP1370641B1 Use of stem cells and cd6-depleted stem cells for inducing tolerance of allogenic transplants and/or for treating leukaemia |
| 08/16/2006 | EP1318991B1 Benzoic acid derivatives and uses thereof |
| 08/16/2006 | EP1292687B1 Regulated antigen delivery system (rads) involving bacteria |
| 08/16/2006 | EP1276853B1 Pneumovirus ns proteins antagonising the interferon (ifn) response |
| 08/16/2006 | EP1272225B1 Lipid-based systems for targeting diagnostic agents |
| 08/16/2006 | EP1259234B1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 08/16/2006 | EP1198233B1 Sulfonamide and sulfamide substituted imidazoquinolines |
| 08/16/2006 | EP1181020B1 Vitamin d derivatives for the teatment of systemic lupus erythematosus |
| 08/16/2006 | EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 08/16/2006 | EP1137410B1 Novel 4-dedimethyl aminotetracycline derivatives |
| 08/16/2006 | EP0980362B1 Substituted heterocycles and their use in medicaments |
| 08/16/2006 | EP0880523B1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/16/2006 | EP0809655B1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION |
| 08/16/2006 | EP0314705B2 A novel family of primate hematopoietic growth factors |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1819845A Medicinal composition containing NF-kappa B decoy for treating and preventing respiratory diseases and method of using the same |
| 08/16/2006 | CN1819776A Process for producing liquid formulation containing raw yeast and liquid formulation |